Patent ID: 11884669
Assignee: KING FAISAL UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 16:
17. A pharmaceutically acceptable composition comprising a therapeutically effective amount of a compound selected from the group consisting of:
4-((3-chlorophenyl)amino)-1H-pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid (1);
4-(m-tolylamino)-1H-pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid (2);
4-((3-methoxyphenyl)amino)-1H-pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid (3);
4-((3-(dimethylamino)phenyl)amino)-1H-pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid (4);
4-((4-chlorophenyl)amino)-1H-pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid (5);
4-(p-tolylamino)-1H-pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid (6);
4-((4-methoxyphenyl)amino)-1H-pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid (7);
4-((4-(dimethylamino)phenyl)amino)-1H-pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid (8);
4-((3-isopropylphenyl)amino)-1H-pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid (9);
4-((3-(dimethylcarbamoyl)phenyl)amino)-1H-pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid (10);
4-((3-(N,N-dimethylsulfamoyl)phenyl)amino)-1H-pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid (11);
4-((2-methylpyridin-4-yl)amino)-1H-pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid (12);
4-((3-chlorobenzyl)amino)-1H-pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid (13);
4-((pyridin-3-ylmethyl)amino)-1H-pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid (14);
4-((3-(dimethylamino)propyl)amino)-1H-pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid (15);
4-((3-(4-methylpiperazin-1-yl)propyl)amino)-1H-pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid (16); and a pharmaceutically acceptable salt, ester, stereoisomer, or solvate thereof; and
a pharmaceutically acceptable carrier.